Pressure Biosciences (PBIO) Stock Soars To New High: Here is Why

Among the many stocks that managed to record handsome gains on Wednesday, the gains made by the Pressure Biosciences Inc (OTCMKTS:PBIO) stock were one of the more notable. Although there was no news about the stock yesterday, the Pressure Biosciences stock was in sharp focus among many investors and managed to clock gains of as much as 68%.

However, in this regard, it might be a good move for investors to perhaps take a look at an announcement made by the company last week. Back on July 1, Pressure Biosciences had announced that it was looking to apply its Ultra Shear Technology platform with the purpose of creating formulations in a wide range of nutraceuticals that are more potent and have more therapeutic value.

While it is difficult to say if that announcement made last week was the trigger for the rally in the Pressure Biosciences stock on Wednesday, it cannot be denied that that announcement was a significant one and could have long term ramifications for the company. The usage of the platform for formulating new nutraceuticals is also expected to result in controlled dosing and to lower costs for certain therapies. Investors could consider keeping the Pressure Biosciences stock in their watch lists.

Market Reaction:

On Wednesday, PBIO stock surged 68.50% at $4.01 with more than 666k shares, compared to its average volume of 10K shares. The stock had moved within a range of $2.4400 – 4.0300 after opening the trade at $2.50. Over the past 52-week, the stock has been trading within a range of $1.2900 – 4.0300.

Related Posts

About The Author